MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series
収録刊行物
-
- Cancer Immunology, Immunotherapy
-
Cancer Immunology, Immunotherapy 68 (6), 983-990, 2019-04-16
Springer Science and Business Media LLC